Multiple myeloma is a blood disorder that originates in the bone marrow. Approximately 20,000 to 30,000 new cases of multiple myeloma are diagnosed in the United States each year. Signs and symptoms of myeloma can include: fatigue, low blood counts, abnormal calcium levels, kidney dysfunction, bone disease on imaging. Diagnosis of myeloma often requires lab testing of the blood and bone marrow.
There are many treatment options for multiple myeloma, which can include oral medications, injectable medications, IV infusions. In some patients, evaluation for bone marrow transplant is considered. Choosing treatment for an individual patient with myeloma is based on many factors, which can include: patient symptoms, patient age, lab testing, pathology results, and imaging studies.
Dr. Raymond Tsao
Dr. Vijay Narendran
Sujal Shah, MD
Sujal Shah, MD is a former assistant professor of medicine at the University of Texas at Austin and an associate instructor of clinical medicine at Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. Dr. Shah completed his internal medicine residency and his hematology and oncology fellowship at Tulane University Hospital and Clinics in New Orleans.
Dr. Shah is currently seeing patients with different types of cancers, with a focus on lung cancer and head and neck cancers. Dr. Shah is a member of the American Society of Clinical Oncology and the American Society of Hematology.